Pride: professional is personal

by Gareth Kitson, RPS Professional Development and Engagement Lead

Like everyone, my professional identity is informed by my personal life. Achieving that identity has at times been a struggle and is always a work in progress. It’s something I have learned to take pride in.

As I have progressed through my career, I’ve realised that identifying as a gay man is a bigger part of my identity than I once thought. 

Speaking up

I have had countless conversations with colleagues about what it is like to be a gay man living in London. I’ve spoken about how I have faced prejudice and discrimination because of my sexual identity.  I have highlighted the changes in sexual health provision and how HIV is no longer associated with the falling tombstone of the 1980s. I’ve updated people on how PrEP is transforming the prevention agenda for men who have sex with men.

Being a pharmacist is a huge part of my identity and my sexual identity is too. It often intertwines with other aspects of my personality, including my professional life.  If I feel accepted and safe in my working environment, I’m more creative, better engaged and form stronger working relationships.

Pride

This is why I’m really proud that the RPS is walking in the Pride in London Parade in 2019. 

This is the first time we’ve done something like this.  I’m proud that my professional body recognises both my professional and personal identity. Members of staff and members of RPS will be walking in the Parade on July 6th – if you see us, give us a wave! #wearepharmacy.

Why Pride matters


By Gareth Kitson, RPS Professional Development and Engagement Lead

I had known for a long time that I was gay but had never had to acknowledge it. I never engaged with the LGBT+ community at Uni as I had a ready-made group of friends. I wasn’t confident enough to engage with members of the community as I felt I had to behave in a certain way.  After moving to London I was pushed into the one of the most vibrant and diverse communities in the world and wasn’t ready for the effect it would have on me.

Fitting in

Every aspect of the LGBT+ community had “tribes” or “communities” and I really struggled to find my place.  I also found it really hard to make friends outside of a dating environment.  Most gay men will tell you the same story – insecurity, isolation and the struggle to “fit in”. 

In July 2012 I was out shopping on Oxford Street and accidentally stumbled on the Pride in London Parade.  I felt overwhelmed, curious and confused as to what was happening.  I stopped and watched the entire Parade pass by and spent the rest of the day reflecting on what I had just seen.

Not alone

For the first time, I suddenly felt that I wasn’t alone.  I suddenly realised that there were other people living in the same city as me who identified as a member of the LGBT+ community.  There were opportunities to meet people who may have gone through the same experiences as you, be it coming to terms with your own identity or coming out to your family and friends. 

This one day showed me that people from all backgrounds can stand next to each other and be proud of who they are.  That families can gather and show their children that it is OK for a man to love a man and that some of their friends may have two mummies instead of a mummy and a daddy. 

It was heart-warming, confidence-boosting and empowering when I finally realised that I wasn’t alone.  That I could live my life as I wanted, being true to who I really was, in the city I now called home. That’s why Pride matters.

Members of staff and members of the RPS will be walking in the Parade on 6th July. If you see us, give us a wave #wearepharmacy.

The role of pharmacists in the PCN revolution

By Ravi Sharma (Director for England, RPS) and Graham Stretch (Clinical Director, Brentworth PCN and Vice President, Primary Care Pharmacy Association)

The NHS in England is set for transformation as the Long Term Plan is put into place over the next decade to ensure the NHS is fit for purpose in the future.

The Plan’s key aims are to:

• ensure everyone gets the best start in life,
• deliver world class care for major health problems
• and support people to age well

Read more The role of pharmacists in the PCN revolution

What’s it like to be a guest at a meeting of the Welsh Pharmacy Board?

At our recent Welsh Pharmacy Board meeting, RPS members Nia Sainsbury, Medicines Information Pharmacist from Bridgend, and Boots Pharmacist Simon Taylor, came along to observe the open business proceedings.
We caught up quickly with them to see what they’d made of the experience.

Nia Sainsbury and Simon Taylor
Nia Sainsbury and Simon Taylor

Can you tell us why you decided to come along to the Welsh Pharmacy Board meeting today?

NIA – What motivated me and engaged me to come today is having been involved with the palliative and end of life care policy. So that made me think about what other things are RPS Wales engaged with at the moment. Coming here today I’ve seen that it’s lots of different issues that are being looked at, and how RPS Wales can lead on those issues, like the really interesting presentation we had on advanced therapies.

What have been your main takeaway messages from attending today?

SIMON – I think the enormity of the scale they (the WPB) have to consider each issue with. It’s like they’re looking into the future, how far they have to consider the impact of the decisions they’re making will have. So you don’t appreciate that from the outside always, seeing how much they have to consider, how many different roles there are in there. The other things that people do there, not necessarily in terms of different agendas, but actually there is a lot of representation from different bodies in there.

What would you say are the benefits of pharmacists being able to attend board meetings?

NIA – I very strongly believe that all pharmacists should be members of the RPS, and open board meetings are one of the many things we can do to engage all pharmacists and show them the benefits of membership. When you see the policies, the Palliative Care Policy for instance, being brought out and actually the changes that creates, it’s really useful.

What’s been your overall impression of the Welsh Pharmacy Board?

SIMON – The impact of decisions that are made there have quite wide-reaching effects, so taking everything into consideration from the pharmacy point of view, the health point of view, the public point of view, everyone’s kind of representing that, giving a nice rounded opinion in that decision making process. In terms of the decision-making process, it’s clear they’re not going to miss things.

Would you recommend attending board meetings to other RPS members?

NIA – Yes absolutely!

SIMON – I wasn’t quite sure what to expect, there were only 3 guest observers there which was a little bit daunting at first, but perhaps there can be more (members attending) added to that in future. Coming in as an observer as well, we were given an opportunity to get our opinions across, which I think is really important, from whatever place we’re representing, whether hospital, community or education. That’s important I think, to put that opportunity out there so members can contribute.

The next meeting of the Welsh Pharmacy Board will take place in September. If you’d like to attend, just drop us an email at Wales@rpharms.com to reserve your place.

System leadership: how to get involved

By Amandeep Doll, RPS Regional Liaison Pharmacist

The NHS landscape is always changing and it can be difficult to know where to start for pharmacists who want to get involved in their local health and care systems.

You may have recently heard a lot about ‘systems’ in healthcare – but what are they really about? In short, they mean working collaboratively across health and social care boundaries to improve patient and public outcomes.

Current systems

The systems in England which plan, organise and deliver health and care services are called Integrated Care Systems (ICS), Sustainability and Transformation Partnerships (STPs) and Primary Care Networks (PCNs). The NHS Long Term Plan will be delivered through these systems, which will work in collaboration with existing commissioning, secondary care providers and local authorities.

Pharmacists must be part of these structures at leadership level to ensure the future success of the profession at every level of practice. Our impact in systems is maximised when we integrate with the wider health and social care team.

Our challenge

The challenge for pharmacists is to deliver system-wide medicines optimisation, creating a collective sense of responsibility across different areas of pharmacy, organisations and individuals. This has the potential to dramatically improve population health.

To do this, pharmacists must be formally recognised by these systems and a framework established to support pharmacy integration and build a collaborative approach.

But where on earth do you start? If you’re keen to get involved, we can help you explore leadership opportunities within healthcare.

We can help

Our brand new online tool A systems approach to medicines optimisation and pharmacy will help you navigate the opportunities for pharmacy service development and medicines optimisation within local health and care systems.

It identifies six ways you can support effective system leadership and is packed full of practical advice to encourage collaborative working. It also provides checklists of the resources, standards and guidance needed to build knowledge and skills, along with case studies of how pharmacists have improved medicines optimisation and patient care.

A systems approach to medicines optimisation and pharmacy is part of our support for members working to improve medicines optimisation. I really hope that other pharmacists will contribute their experiences and share good practice in this rapidly changing environment. We need to see what works and what doesn’t so we can all learn to lead better.

Why not submit your own leadership case study?

Download our case study template and email it to england@rpharms.com

Related resource: Medicines Optimisation

Salbutamol – landmark asthma treatment

by John Betts, Keeper of the RPS Museum

2019 marks the 50th anniversary of the landmark asthma treatment Salbutamol becoming commercially available in the UK. Salbutamol is still widely used today to relieve symptoms of asthma and COPD such as coughing, wheezing and feeling breathless. It works by relaxing the muscles of the airways into the lungs, making it easier to breathe.

Launched in 1969 with the brand name Ventolin, Salbutamol revolutionised the treatment of bronchial asthma.

It treated bronchospasm far more effectively compared with previous bronchodilators and had fewer side effects.

To understand how much of a breakthrough Salbutamol was in the treatment of asthma, it’s first worth comparing it to the drugs that were used to treat asthma before 1969.

One of the main drugs used for treating asthma in the mid-1960s was isoprenaline. This is a powerful bronchodilator and was used to relieve bronchospasm. However, the side effects include a sudden increased heart rate. Between 1963 and 1968 in the UK there was an increase in deaths among people using isoprenaline to treat asthma. This was attributed to overdose due to both excessive use of the aerosols and the high dosage they dispensed.

In the mid-1960s the mortality rate for asthma sufferers had risen to over 2,000 deaths a year. An effective bronchodilator was desperately needed that did not stimulate the heart or affect blood pressure.

Salbutamol was discovered in 1966 by a research team at Allen and Hanburys (a subsidiary of Glaxo). Salbutamol was the first drug that selectively targeted specific receptors in the lungs, inhibiting the production of proteins needed to produce muscle contractions. It works by relaxing the smooth muscle of the airways, opening them up and so lessening or preventing an asthma attack. Not only was Salbutamol a good bronchodilator, it lasted longer than isoprenaline, and inhalation caused fewer side effects.

In addition to the effectiveness of the drug, the method of administration itself was also revolutionary. The Ventolin inhaler was designed to ensure metered aerosol doses of Salbutamol were inhaled straight into the patient’s lungs.

The drug was an instant success.

The only real deficiency of Salbutamol was its short duration of action; at 4 hours it couldn’t prevent night-time asthma attacks. In response to this the pharmaceutical manufacturer Glaxo aimed to develop a longer acting drug. The result of their research was Salmeterol. Launched in 1990 with the brand name Serevent, it had a 12-hour duration of action.

50 years on Salbutamol is still on the World Health Organization’s List of Essential Medicines; a testament to the major role it continues to play in the treatment of asthma. 

Visit the RPS Museum Mon-Fri 9am-5pm

Every day is a school day for Chris

By Chris Maguire, pharmacist and marketing manager at Beckton Dickinson

I studied pharmacy at Queens University, Belfast.

I completed my pre-reg in community pharmacy, in a small chain, in the same town I went to school. Once I had finished, I did a few locums for the same company and was offered a relief position. I had friends in England who told me about the offers they’ve been receiving. I was tempted…and made the move to the “mainland”. I applied for few jobs and got one with Lloyds pharmacy, living in Liverpool. I moved from relief manager, to pharmacy manager to cluster manager. I was really enjoying work and career progression, but I had always wanted to travel so I took a career break for a year and travelled.
I even got to work in a hospital in Sydney for 6 months of my 14 months adventure.

When I came home, I got a job at Interface Clinical Services, working in primary care. Delivering services such as osteoporosis, diabetes and asthma reviews. Again, I started making my way up – from service development, to a national lead pharmacist.

I managed a team of 90 pharmacists running reviews, clinics, hospital work and made sure they were trained.  I had always been focused on delivering care based on NICE guidance or the latest evidence in disease areas.
I think that with more responsibility, pharmacists can help make a change on a bigger scale.

In my roles in primary care, I learned how clinical systems work in GP land, how the mechanics of QOF work.  I strongly believe that with up-skilling pharmacists to be experts in specific disease areas and pharmacy integration we can create better primary care services. 

I’d been working on a diabetes service specifically for quite a while and think there is so much more pharmacists could do.  It was because of my experience in primary care that I was approached by industry to join as a project manager and help to deliver value based health care. A concept where value is the outcome for the patient over the cost. I thought this was an amazing opportunity to help on a bigger scale and to gain experience in industry.

I had been approached by industry before with an MSL opportunity. I looked into their portfolio, their evidence, the guidelines and felt that it wasn’t a good fit and I couldn’t hang my pharmacist hat on that. So, I stayed with Interface for another 2 years, gaining more experience and exposure working with federations, CCGs, hospitals, AHSNs, NICE and others. It’s not always how fast you can get to the new job but going for the right job.

After working for a year as a project manager, I applied for a marketing manager job. I didn’t have any experience in marketing, but I do understand how the NHS and the supply chain works.  I understand how the use of data can help improve outcomes, which helped me get the job! I’ve now also enrolled on a course to become CIM (Chartered Institute of Marketing) certified at diploma/degree level to make sure I have all the basics and grounding needed.

Every day is a school day! 

Find out more about how to get a job in pharmaceutical industry

Peer Discussion day has arrived

The moment has arrived.  RX and I are sitting opposite one another in the Bell Room at RPS HQ.  Messrs Squire and Hills, grandees from pharmacy history looking down at us from the wall and behind us the artefacts of the museum (I’m hoping there isn’t a thumbscrew in the museum and that this is going to be a free flowing discussion).

Read more Peer Discussion day has arrived